miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL

Guowen Wang1, Xuefang Tao1, Linlin Peng2

  • 1Department of Respiratory Medicine, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, China.

Bioengineered
|May 25, 2022
PubMed

Insights

Pulmonary arterial hypertension (PAH) involves increased miR-155-5p targeting PYGL in pulmonary artery smooth muscle cells (PASMCs). This pathway drives cell proliferation and migration, suggesting new therapeutic targets for PAH.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Physiology

Background:

  • Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease with high mortality.
  • The miR-155-5p/PYGL pathway has been implicated in PAH pathogenesis.
  • Understanding cellular mechanisms in PAH is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of miR-155-5p in regulating hypoxia-induced pulmonary artery smooth muscle cell (PASMC) function.
  • To elucidate the molecular mechanism by which miR-155-5p affects PASMCs in the context of PAH.
  • To identify potential therapeutic targets within the miR-155-5p/PYGL pathway for PAH treatment.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) to identify key pathways.
  • In vitro experiments using hypoxia-treated PASMCs.
  • Quantitative real-time PCR (qRT-PCR) and Western blot to measure gene and protein expression.
  • Cell proliferation (CCK-8), migration (Transwell), and cell cycle assays (Flow cytometry).
  • Dual-luciferase reporter assay to confirm direct interaction between miR-155-5p and PYGL.

Main Results:

  • Hypoxia increased PASMC proliferation, VEGF, HIF-1α, and miR-155-5p levels, while decreasing PYGL expression.
  • miR-155-5p inhibition suppressed hypoxia-induced PASMC proliferation, migration, and altered cell cycle progression.
  • Direct regulation of PYGL by miR-155-5p was confirmed.
  • Silencing PYGL reversed the effects of miR-155-5p inhibition on PASMCs.

Conclusions:

  • Increased miR-155-5p in hypoxia-stimulated PASMCs promotes proliferation, migration, and cell cycle progression by directly targeting PYGL.
  • The miR-155-5p/PYGL axis represents a significant mechanism in PAH pathogenesis.
  • This pathway offers potential novel therapeutic strategies for treating pulmonary arterial hypertension.